2-Heptyl-Formononetin Increases Cholesterol and Induces Hepatic Steatosis in Mice
Figure 2
Glucose homeostasis of cholesterol fed C57BL/6 mice (–25) supplemented with either formononetin or 2-heptyl-formononetin (C7F) for three weeks (Experiment 1). (a) Glucose clearance assessed by oral glucose tolerance test (2 g/kg glucose). (b) Fasting plasma glucose concentration. Graphs show mean ± SEM.
